SL
GMED icon

Salomon & Ludwin’s Globus Medical GMED Stock Holding History

Salomon & Ludwin’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.4K Hold
176
– – ﹤0.01% 1442
2026
Q1 		$15.5K Hold
176
– – ﹤0.01% 1266
2025
Q4 		$15.9K Sell
176
-1
-0.6% -$76 ﹤0.01% 1080
2025
Q3 		$10.7K Buy
177
+27
+18% +$1.55K ﹤0.01% 1254
2025
Q2 		$9.09K Buy
+150
New +$9.69K ﹤0.01% 497

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Salomon & Ludwin's GMED Position: Q2 2026 in Review

Salomon & Ludwin held its Globus Medical (GMED) position steady in Q2 2026 at 176 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1442.

Salomon & Ludwin first reported a position in GMED in Q2 2025 and has held it in 5 quarters since. The position peaked at $15.9K in Q4 2025. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Salomon & Ludwin held 176 shares of Globus Medical worth $13.4K as of Q2 2026.
  • Salomon & Ludwin left its Globus Medical share count unchanged in Q2 2026.
  • Globus Medical made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #1442 holding.
  • Salomon & Ludwin first reported a position in Globus Medical in Q2 2025 and has held it in 5 quarters since.
  • Salomon & Ludwin's Globus Medical position peaked at $15.9K in Q4 2025.
  • 596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.